Synthesis of human molecules by foreign organisms for pharmaceutical purposes


  • Artificial manufacture of human hormones

Incidence

The insertion of insulin-producing genes into bacteria enabled cheaper, large-scale production of insulin hormone.

A 2019 report valued the market in therapeutics, mostly arising through recombinant genetic technologies, at more than US$315 billion.

Claim

  1. The biggest fear about genetic engineering of medicaments is that it would be used for social purposes and not medical purposes.


© 2021-2024 AskTheFox.org by Vacilando.org
Official presentation at encyclopedia.uia.org